Orphan drugs in Australia

被引：5
|
作者：
Herkes, Geoffrey K. [1 ,2 ,3 ]
机构：
[1] Royal North Shore Hosp, Dept Neurol, St Leonards, NSW, Australia
[2] Univ Sydney, Kolling Inst, Med, Sydney, NSW, Australia
[3] Advisory Comm Prescript Med Therapeut Goods Adm, Canberra, ACT, Australia
来源：
EXPERT OPINION ON ORPHAN DRUGS | 2016年 / 4卷 / 12期
关键词：
Orphan drug program; review; rare diseases; oncology;
D O I：
10.1080/21678707.2016.1257383
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1195 / 1197
页数：3
相关论文
共 50 条
  • [21] Orphan drugs in Europe
    Emma Dorey
    Nature Biotechnology, 1999, 17 (8) : 737 - 737
  • [22] Drugs and orphan diseases
    Blin, Olivier
    Micallef, Joelle
    THERAPIE, 2020, 75 (02): : 131 - 132
  • [23] ORPHAN DRUGS IN USA
    HANESSE, B
    TRECHOT, P
    NETTER, P
    ROYER, RJ
    REVUE DE MEDECINE INTERNE, 1992, 13 (02): : 93 - 96
  • [24] MONOPSONY OF ORPHAN DRUGS
    Afify, Y.
    VALUE IN HEALTH, 2017, 20 (05) : A69 - A69
  • [25] Rescuing orphan drugs
    Coombes, Rebecca
    BMJ-BRITISH MEDICAL JOURNAL, 2023, 381
  • [26] Radiopharmaceuticals as orphan drugs
    Swanson, DP
    SEMINARS IN NUCLEAR MEDICINE, 1996, 26 (02) : 91 - 95
  • [27] DEVELOPMENTS IN ORPHAN DRUGS
    CARTER, MJ
    BENNETT, AR
    FOOD AND DRUG LAW JOURNAL, 1989, 44 (06): : 627 - 632
  • [28] Pricing of orphan drugs
    Leonard, J. V.
    Richmond, S.
    LANCET, 2009, 373 (9662): : 462 - 462
  • [29] Orphan drugs revisited
    McCabe, C
    Tsuchiya, A
    Claxton, K
    Raftery, J
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2006, 99 (05) : 341 - 345
  • [30] Orphan DrugsOrphan drugs
    Jürgen R. Schäfer
    Claus F. Vogelmeier
    Der Internist, 2019, 60 (4): : 396 - 398
12345